Another study, not yet published, is SURMOUNT-OSA, a clinical trial of 52-weeks that examined the efficacy and safety of TZP versus placebo in obese participants and an established OSA diagnosis for treatment of moderate and severe OSA (102)
Hepatology 66 , 449465 (2017)
Poor Prescription Management Means More Work for Nutritionists Managing GLP-1 Side Effects There are also an unfortunately high number of cases emerging where physicians are prescribing GLP-1 therapies without consulting nutritionists or adequately assessing their patients for eating disorders
During your consultation, the dermatologist will ask questions about your medical history, lifestyle habits, and diet
This is not universal GLP-1 coverage, and patients should not assume every medication, dose, plan, or diagnosis will qualify
Getting started is easy simply text, call, email, or WhatsApp our patient care coordinators to receive our informational brochure, which includes a complete list of our services and transparent pricing